Zaditor Articles
FDA clears OTC use of Akorn's ketotifen fumarate
6 August 2007
SANDOZ WINS JAPANESE SUIT
26 April 1993
PATENT INFRINGEMENT SUIT OVER SANDOZ' ZADITEN
13 April 1992
Showing 1-5 of 5 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
